Abstract: Provided is a method for medical imaging in a patient in need thereof, comprising administering a pharmaceutical composition comprising LS301 to the patient via slow intravenous injection at a dose between about 0.001 mg/kg and about 0.5 mg/kg. Also provided is a method for surgical removal of cancer in a patient in need thereof, comprising administering a pharmaceutical composition comprising LS301 to the patient via slow intravenous injection at a dose between about 0.025 mg/kg and about 0.001 mg/kg before surgery for cancer resection; imaging via near-infrared fluorescence of the LS301 to identify malignant tissue in the patient, wherein each patient serves as their own control in terms of the near-infrared (NIR) light on versus the NIR light off; and surgically removing the image-identified malignant tissue from the patient, wherein the imaging step occurs during the surgical removal step.

Abstract: A system for adjusting an interpupillary distance and an eye relief distance of a headset. The system can determine an interpupillary distance of a user and an eye relief distance of the user. The system can cause an adjustment assembly to adjust a first distance between the first lens and the second lens along a first axis based at least in part on the interpupillary distance and cause the adjustment assembly to adjust the optical assembly a second distance along a second axis that is orthogonal to the first axis based at least in part on the eye relief distance.

Abstract: A method and system is disclosed herein for decoupling billing for web services from the application logic which governs those web services by instrumenting a web services stack to monitor SOAP envelopes for pre-determined elements and to use those elements to determine questions as to authorization for solvency as well as calculate charges for said web services.

Abstract: This disclosure generally relates to methods for reducing the risk of preterm birth in a pregnant human female patient that include subcutaneous administration of HPC. The disclosure relates in part to the discovery that subcutaneous administration of HPC is actually feasible and can result in sufficient plasma levels of HPC in pregnant patients that can reduce the risk of preterm birth.

Abstract: This invention relates to a composition comprising: (a) 10-20 wt % acidifying bacteria, (b) 30-40 wt % of an oxidising agent, (c) 5-15 wt % of an organic acid, and (d) 1-10 wt % of a chelating agent. The invention also relates to a method of removing uric acid from a waste pipe comprising the step of inserting the composition into the waste pipe.

Abstract: This disclosure generally relates to methods for reducing the risk of preterm birth in a pregnant human female patient that include subcutaneous administration of HPC. The disclosure relates in part to the discovery that subcutaneous administration of HPC is actually feasible and can result in sufficient plasma levels of HPC in pregnant patients that can reduce the risk of preterm birth.

Abstract: This disclosure generally relates to methods for reducing the risk of preterm birth in a pregnant human female patient that include subcutaneous administration of HPC. The disclosure relates in part to the discovery that subcutaneous administration of HPC is actually feasible and can result in sufficient plasma levels of HPC in pregnant patients that can reduce the risk of preterm birth.

Abstract: This disclosure generally relates to methods for reducing the risk of preterm birth in a pregnant human female patient that include subcutaneous administration of HPC. The disclosure relates in part to the discovery that subcutaneous administration of HPC is actually feasible and can result in sufficient plasma levels of HPC in pregnant patients that can reduce the risk of preterm birth.

Abstract: This disclosure generally relates to methods for reducing the risk of preterm birth in a pregnant human female patient that include subcutaneous administration of HPC. The disclosure relates in part to the discovery that subcutaneous administration of HPC is actually feasible and can result in sufficient plasma levels of HPC in pregnant patients that can reduce the risk of preterm birth.

Abstract: The disclosed system may include a communication device configured to receive wireless synchronization information for display content, a lens, an optical device, and a controller configured to determine that the display content is in a field of view of the lens, and in response to determining that the display content is within the field of view of the lens, cause the lens to selectively allow the display content to pass through the lens based on the wireless synchronization information. Various other related methods and systems are also disclosed.

Abstract: The disclosed system may include a communication device configured to receive wireless synchronization information for display content, a lens, an optical device, and a controller configured to determine that the display content is in a field of view of the lens, and in response to determining that the display content is within the field of view of the lens, cause the lens to selectively allow the display content to pass through the lens based on the wireless synchronization information. Various other related methods and systems are also disclosed.

Abstract: A method includes providing frames of video data for being displayed by a head mounted display (HMD). Pixel data is encoded in a pixel of at least some of the video data frames, the encoded pixel data defining a focal state of an optics block of the HMD for displaying the respective frame of the video data to a user. The predetermined focal state is determined from a plurality of available focal states of the optics block, each focal state corresponding to a different focal plane of a virtual image generated based on the video data. The pixel used for encoding may be disposed outside a region of the frame that is displayable by the HMD.

Abstract: A method includes providing frames of video data for being displayed by a head mounted display (HMD). Pixel data is encoded in a pixel of at least some of the video data frames, the encoded pixel data defining a focal state of an optics block of the HMD for displaying the respective frame of the video data to a user. The predetermined focal state is determined from a plurality of available focal states of the optics block, each focal state corresponding to a different focal plane of a virtual image generated based on the video data. The pixel used for encoding may be disposed outside a region of the frame that is displayable by the HMD.

Abstract: This disclosure generally relates to methods for reducing the risk of preterm birth in a pregnant human female patient that include subcutaneous administration of HPC. The disclosure relates in part to the discovery that subcutaneous administration of HPC is actually feasible and can result in sufficient plasma levels of HPC in pregnant patients that can reduce the risk of preterm birth.

Abstract: This disclosure generally relates to methods for reducing the risk of preterm birth in a pregnant human female patient that include subcutaneous administration of HPC. The disclosure relates in part to the discovery that subcutaneous administration of HPC is actually feasible and can result in sufficient plasma levels of HPC in pregnant patients that can reduce the risk of preterm birth.

Abstract: The disclosure is directed in part to extended release compositions that include hydroxy progesterone caproate. For example, provided herein is a therapeutic microparticle composition comprising a plurality of microparticles, wherein the microparticles each comprise poly (lactide-co-glycolide) and hydroxyprogesterone caproate.

Abstract: A method and system is disclosed herein for decoupling billing for web services from the application logic which governs those web services by instrumenting a web services stack to monitor SOAP envelopes for pre-determined elements and to use those elements to determine questions as to authorization for solvency as well as calculate charges for said web services.

Abstract: This disclosure generally relates to methods for reducing the risk of preterm birth in a pregnant human female patient that include subcutaneous administration of HPC. The disclosure relates in part to the discovery that subcutaneous administration of HPC is actually feasible and can result in sufficient plasma levels of HPC in pregnant patients that can reduce the risk of preterm birth.

Abstract: The present invention relates to methods and kits for reducing the occurrence of preterm delivery and other pregnancy-related conditions in pregnant female subjects exhibiting one or more risk factors for preterm delivery and other pregnancy-related conditions. For example, the present invention relates to methods for reducing the occurrence of preterm delivery in a pregnant female subject having no history of preterm delivery and exhibiting one or more risk factors for preterm delivery (e.g., smoking during pregnancy). The methods and kits provide for the administration of a steroid hormone to the pregnant female subject.

Abstract: A balance between customer satisfaction and cost to providing customer care can be achieved based on the use of online interaction classification techniques. Such techniques can use measurements such as a log likelihood ratio to determine if an interaction should be removed from automation to live support if it appears necessary.